PTCB Dosage Forms, Doses and Storage: forms, routes and in-use clocks

What this topic actually asks of you

Domain 1 is Medications — 35% of the PTCE — and this topic owns the three knowledge areas about the shape a drug arrives in and how you keep it good:

Strengths/doses, dosage forms, routes of administration, special handling and administration instructions, and duration of drug therapy

KA 1.4;

Drug stability (e.g., oral suspensions, insulins, reconstitutables, injectables, vaccinations)

KA 1.7; and

Proper storage of medications (e.g., temperature ranges, light sensitivity, restricted access)

KA 1.8. Together that is roughly an eighth of the exam (three of Domain 1's eight knowledge areas, and Domain 1 is 35% — PTCB does not publish per-knowledge-area weights), and the three are one idea seen three ways: the form is not decoration. The box a drug comes in decides where it goes in the body, how often it is taken, whether it can be cut, and the day it stops being good.

The good news is that it is mostly pattern, not memory. A suffix on a label (ER, DR, SL, ODT, XL) tells you the form, the form tells you the route, the route tells you the handling rule, and the label's section 16 tells you the storage. Learn the handful of rules below — do not crush the ones that are slow-release, keep the liquid cold once it is mixed, count the days after you open the pen — and you can answer a product you have never held.

What a technician does with this. Everything clinical ends the same way: refer to the pharmacist. You do not decide that a tablet may be split, that a patient may switch from one insulin to another, or that a cloudy bottle is safe to dispense. Your job is recognition and the right hand-off: to notice that the patient is asking to crush a capsule that must not be crushed, that a reconstituted suspension has a discard clock a patient may not know about, that a fridge that has been unplugged is now a patient-safety question. Knowing why is what makes you look twice.

What this topic does not do. It does not teach you to dose a drug, and it does not ask you to memorize a storage chart. The figures below are the high-yield ones, each tied to the wording of a real FDA label (quoted from the label itself) or to a published agency page, and every drug is drawn from the Top-200 drug list this course is built on. Where a drug in a classic example is not on that list, it is marked not in the Top-200 rather than dropped.

The dosage forms, named (KA 1.4)

A dosage form is the physical thing a drug is made into — the tablet, the syrup, the patch, the pen. FDA keeps a standard list of dosage-form names (the Structured Product Labeling, or SPL, dosage-form terminology) so that every label uses the same word for the same thing. You are asked to recognize the word and what it means, not to recite the list.

The tablet family. A film-coated tablet carries a thin polymer coat (easier to swallow, masks a taste). An enteric-coated (EC, or DR on the label) tablet is coated so it dissolves past the stomach — the coat is the point, so it must not be crushed. A chewable tablet is meant to be chewed. An orally disintegrating tablet (ODT) dissolves on the tongue. A sublingual tablet is held under the tongue and a buccal tablet is held against the cheek; both are absorbed through the lining of the mouth and are not swallowed whole. An effervescent tablet is dropped in water and fizzes. A caplet is a capsule-shaped tablet. A capsule is a shell (gelatin or another material) around powder, granules or liquid; a softgel is a one-piece soft capsule.

The liquid family. A solution is a clear liquid with the drug fully dissolved. A suspension is a liquid with solid particles dispersed in it and must be shaken before each dose — a reconstituted oral antibiotic suspension is the classic example. A syrup is a solution with sugar (or a sugar substitute). An elixir is a sweetened alcohol-containing solution. An emulsion is one liquid dispersed in another. A tincture is an alcohol extract.

The semisolid and topical family. An ointment (a "greasy" anhydrous base), a cream (softer, rubs in), a gel (a clear, semi-solid), a lotion (pourable, for large or hairy areas), a paste (stiff, stays put), and a foam. A transdermal patch delivers through the skin over hours to days. A suppository is inserted rectally and a vaginal insert vaginally.

The inhaled and injected family. A metered-dose inhaler (MDI) sprays a measured puff; a dry-powder inhaler (DPI) uses the patient's own breath to pull the powder in; a soft-mist inhaler makes a slow aerosol cloud; a nebulizer solution is turned into a mist by a machine. An injectable may be a ready solution, a suspension (cloudy, must be resuspended), a powder for reconstitution (mixed before use), or a lyophilized powder (a freeze-dried cake to be reconstituted). A prefilled syringe or a pen is a ready-to-inject device.

The ophthalmic and otic family. Ophthalmic drops or ointments are for the eye; otic drops are for the ear. The two are not interchangeable — an otic product's own label says "Do not use in the eyes", which is exactly why the technician is the last check before the wrong bottle leaves the counter.

Routes, and which form goes with which

The route is the path into the body; the form has to match it.

The two you are tested on most are IM vs SC and oral vs SL: an insulin pen is SC; an epinephrine auto-injector is IM (into the outer thigh); nitroglycerin for angina is SL, and swallowing it destroys the point (next section).

Why the route matters: first-pass, and sublingual nitroglycerin

When a drug is swallowed, it is absorbed from the gut into the portal vein, which carries it straight to the liver — where much of it can be broken down before it ever reaches the rest of the body. That first trip through the liver is the first-pass effect (first-pass metabolism). It is why some oral doses are far larger than their injected equivalents.

A route that puts the drug into the bloodstream without that first pass — sublingual, buccal, transdermal, inhalation, and injection — avoids or partly avoids the liver. The exam's example is sublingual nitroglycerin for angina. It is placed under the tongue because the drug is absorbed there straight into the blood; swallowed, it would be largely destroyed by the liver before it could act. The nitroglycerin label gives the route plainly — "Administer one tablet under the tongue or in the buccal pouch at the first sign of an acute anginal attack" — and puts the onset of the effect at "approximately 1 to 3 minutes after sublingual nitroglycerin administration".

What a technician does: you never convert a drug from one route to another. If a patient asks "can I just swallow it?", the answer is "let me get the pharmacist."

Do not crush, do not open

Some forms exist because of the way they release the drug, or because the drug is irritating to the mouth and throat. Crushing or opening them changes the dose the patient actually gets — dumping a whole day's release into the bloodstream at once, or exposing a mucous membrane to a drug it was never meant to touch. The reference a pharmacy keeps behind the counter is ISMP's list "Oral Dosage Forms That Should Not Be Crushed" — the AHRQ PSNet patient-safety library carries the citation (Mitchell JF; ISMP; 2008); the reasons below are this course's own grouping, and the wording that flags a product comes from the product's own label.

A label says it in the Dosage and Administration or How Supplied section. Toprol-XL (metoprolol succinate) is a scored tablet that may be divided, yet its label still warns "do not crush or chew the whole or half tablet". Any ER / XR / SR / CR / LA / XL / DR / EC product carries the same warning in its own words.

The four reasons this course groups them into — this is the part the exam tests:

1. The release is the point — an extended-release (ER, XR, SR, CR, LA, XL) or enteric-coated (EC, DR) form. Crushing an ER tablet releases the whole dose at once (a rising risk of toxicity); crushing an EC tablet destroys the coat that protected the stomach or the drug.
2. The taste or the irritation is the point — a coated tablet or a capsule used to get a bitter or caustic drug past the mouth. Opening such a capsule is a local injury.
3. The drug is hazardous — a cytotoxic or other hazardous drug must not be crushed or opened in a way that makes dust (next section, and the USP <800> rules).
4. The form is not a "pill" at all — a sublingual, buccal or ODT tablet is not swallowed; cutting or crushing it defeats its route.

How to recognize it on the label. The suffix is the tell: ER, XR, SR, CR, XL, LA, DR, EC, MR at the end of a name, and the words "extended-release", "delayed-release", "enteric-coated", "do not crush", "swallow whole", "do not chew" in the label's How Supplied or Dosage and Administration section. A look-alike / suffix pair like Metformin vs Metformin ER is a recognition trap: the two are not interchangeable, and neither is a "same drug, different brand" swap a technician may make.

What a technician does: if a prescription says "crush" or a patient asks to crush an ER, EC or capsule, do not crush it — refer to the pharmacist. The pharmacist may contact the prescriber; you do not.

How often, and for how long (KA 1.4)

Dosing frequency (how often) and duration (how long) are both on the label, and both are worth recognizing at a glance, because they are where a transcription error bites hardest.

Frequencies you will read on a prescription.

Three of these are error-prone abbreviations — you must be able to read them, but you never write them. q.d. (once daily) and q.o.d. (every other day) are on The Joint Commission's Official "Do Not Use" List; q.h.s. / HS (at bedtime) is on ISMP's error-prone list. Each can be misread as another frequency (q.d. as q.i.d.), so write daily, every other day, and at bedtime instead. Both lists are taught in full in reading the sig.

Durations are therapy-specific, and a few are worth knowing because the label fixes them. The azithromycin 5-day pack is the exam's favorite, and the label gives it exactly: "500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5" (Zithromax). Methotrexate for rheumatoid arthritis is dosed once weekly — "The recommended starting dosage is 7.5 mg orally once weekly" — and a daily dose of methotrexate is a well-known serious error, which is why the dose line must be read character for character. Alendronate for osteoporosis is once weekly — "70 mg … once weekly" (Fosamax Plus D) — taken with a full glass of water, upright, on an empty stomach, at least 30 minutes before the first food or drink of the day. A steroid taper is a course that steps down over days or weeks rather than stopping; the reason is that the body's own stomach, at least 30 minutes before the first food or drink of the day. A steroid taper is a course that steps down over days or weeks rather than stopping; the reason is that the body's own cortisol production was suppressed, so a sudden stop is unsafe. Any question about changing a taper, a weekly dose, or a course length is a pharmacist's call.

Strengths: recognition, and the one maximum to know

A strength is how much drug is in a given unit — 10 mg per tablet, 5 mg/5 mL in an oral liquid, 100 units/mL in an insulin. You are asked to recognize a strength and match it to its product, not to memorize every strength on the market. Two cautions the exam leans on:

• A strength is not a dose. metoprolol succinate 25 mg is one tablet; "take 25 mg twice daily" is a dose. Confusing them is the error a single-strength listing exists to prevent.
• A concentrated product is its own error risk. A concentrated insulin (U-200, U-300, U-500) holds more units in the same volume as a U-100 product, so a syringe is not interchangeable between them. U-200 and U-300 insulins are pen-only and must never be drawn into a syringe; for a U-500 vial, only a U-500 syringe may be used, and the pen or syringe matched to that product is the only one to dispense.

The one maximum the exam expects you to know is acetaminophen: never above 4,000 mg in 24 hours, counted across every acetaminophen-containing product. The over-the-counter Drug Facts label carries the liver warning: "Severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen" (an OTC acetaminophen Drug Facts label, read via openFDA 2026-10-06). But follow the product's own Drug Facts limit, which may be lower — many extra-strength OTC labels print "do not take more than 6 tablets in 24 hours", i.e. 3,000 mg, so the same ingredient can carry two different daily numbers. The rule is the lower of the two: never exceed the product's own limit, and never exceed 4,000 mg total. This is the same fact as therapeutic duplication in drug interactions and side effects: the danger is the sum, which is why the technician counts the ingredient, not the box.

Stability: the clock starts when you open it (KA 1.7)

Some drugs are stable until their expiration date only while they are sealed. The moment they are opened, mixed, or taken out of the refrigerator, a new and shorter clock starts — the in-use (or beyond-use) time. The exam's whole stability section is this one idea applied product by product, and the number that matters is the label's, never a general rule.

Where to look. Section 16 of the label — How Supplied / Storage and Handling — states it. A label will often print a small storage table with two columns that look alike: not in-use (unopened) and in-use (opened). Read the in-use column.

Insulin: in-use days, by product

Insulin is the topic's centerpiece, because the in-use number differs by brand and by how the insulin is packaged (a vial you draw from versus a pen). Here is what each product's own label says, quoted:

Two things to carry out of the table. Most insulins are 28 days in-use; degludec is the longer one at 56 days (8 weeks) — so "28 days" is a good default but never a substitute for the label. And a pen kept at room temperature is not to be put back in the refrigerator (the Lantus and NovoLog labels say "Do not refrigerate" for the pen). Unopened insulin is kept refrigerated at 2° to 8°C (36° to 46°F), and it must never be frozen — "Do not freeze … Discard … if it has been frozen" is on every one of these labels.

The GLP-1 pens

The GLP-1 receptor agonists are the same idea in a pen:

• semaglutide (Ozempic): after first use, the pen may be kept 56 days — "56 days at controlled room temperature 15°C to 30°C (59°F to 86°F) or in a refrigerator 2°C to 8°C".
• dulaglutide (Trulicity): each single-dose pen may be kept at room temperature 14 days — "each single-dose pen can be kept at room temperature, not to exceed 86°F (30°C) for a total of 14 days". It is "stored in the original carton" until use and must not be frozen.

Two GLP-1 pens, two different in-use numbers (56 days for the semaglutide pen, 14 days for the dulaglutide pen) — which is exactly why the rule is "read the label's section 16," not "memorize a number."

Reconstituted suspensions: refrigerate or not, and the discard day

An oral antibiotic powder for reconstitution is mixed with water by the pharmacy (or, for some products, by the patient) and then has a short discard-after clock. Whether it goes in the refrigerator depends on the product — and the number of days differs too. The three the exam names:

The teaching point: the discard day is per label, and some suspensions are refrigerated while others are not. Augmentin must be refrigerated and is good 10 days; amoxicillin may be refrigerated but does not have to be, and is good 14 days; cefdinir stays at room temperature for 10 days. There is no common number — 10 days for one, 14 for another — so the label is what you follow, and the label's How Supplied line and the pharmacy's beyond-use date label must agree.

Eye drops: latanoprost before and after opening

A latanoprost eye drop (Xalatan) has two different storage rules — one for the sealed bottle and one for the bottle in use:

• Unopened: "Store unopened bottle(s) under refrigeration at 2°C to 8°C (36°F to 46°F)".
• Opened: "Once a bottle is opened for use, it may be stored at room temperature up to 25°C (77°F) for 6 weeks" (same label).

So a latanoprost bottle arrives cold, and after the patient opens it, it may live in the medicine cabinet for 6 weeks. Note the contrast: the unopened bottle must stay refrigerated, the open bottle need not — which is the opposite of what a learner might guess. The label also says "Protect from light."

Sublingual nitroglycerin: the glass bottle

Nitroglycerin tablets are volatile — the drug evaporates out of the tablet, and it does so faster when the tablet is loose. That is why the label is explicit about the container: "Nitroglycerin should be kept in the original glass container and must be tightly capped after each use to prevent loss of tablet potency". The teaching point: do not transfer the tablets to a pill organizer or another vial — the original, tightly capped glass bottle is the storage, and the label also says Store at Controlled Room Temperature 20°–25°C (68°–77°F).

Vaccines: temperature, diluent, and the clock after reconstitution

Most vaccines that need mixing are supplied as two components — a lyophilized powder (the antigen) and a diluent (a liquid, sometimes an adjuvant suspension). Two rules run through all of them: use only the diluent supplied with that vaccine, and use the reconstituted vaccine within the label's time limit. The four the course's list names (the vaccine items on the Top-200 drug list):

The pattern: Shingrix is the 6-hour one; Arexvy and Abrysvo are the 4-hour ones; Boostrix needs no mixing at all. Every one of these labels also says do not freeze — a frozen vaccine is discarded, not thawed and used.

Storage, the vocabulary (KA 1.8)

A label's storage instruction is written in a defined vocabulary — "controlled room temperature" is not a suggestion, it is a range. USP's General Notices (§10.30 Storage Temperature and Humidity) defines every term, and FDA labels cite it (a label reading "…[see USP Controlled Room Temperature]" is pointing at this table). The definitions below are quoted from the USP 35–NF 30 General Notices (§10.30; USP 35 is the 2012 edition, reached at drugfuture.com/Pharmacopoeia — an archived edition whose definitions are the ones the labels still cite):

Two ideas do most of the work. Controlled room temperature is 20°–25°C (68°–77°F), with excursions permitted to 15°–30°C (59°–86°F) — so a pharmacy that drifts to 28°C on a summer afternoon is still within the allowance, which is exactly why labels read "Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]" (the cefdinir label prints that line word for word). And "cold" and "cool" are different: cold is up to 8°C; cool is 8°–15°C. A "cool place" instruction does not mean the refrigerator by default — though the USP text adds that an article directed to a cool place may be stored in a refrigerator unless its monograph says otherwise.

The vaccine ranges are the CDC's, and they are narrower than the drug vocabulary. CDC guidance says vaccines are stored either refrigerated at 2°C to 8°C (36°F to 46°F) or frozen at −50°C to −15°C (−58°F to +5°F), depending on the product, and warns that "do not freeze" vaccines lose potency if frozen (CDC, Storage and Handling of Immunobiologics, General Best Practices for Immunization, and the Vaccine Storage and Handling Toolkit). Each vaccine's own package insert is the final word — the four vaccine tables above show why a refrigerated vaccine and a frozen vaccine are not interchangeable, and a temperature excursion (a reading outside the product's range) is a call to the vaccine coordinator and, at the pharmacy, to the pharmacist — never a do-it-yourself judgment.

Protect from light and moisture; keep the original container

Three storage habits the exam bundles under KA 1.8:

• Protect from light. Some drugs break down in light; the label says "Protect from light" and the product ships in an amber (light-resistant) bottle or an opaque carton. Latanoprost and the vaccines above carry that instruction; a drug dispensed into a clear vial against its label is a mistake.
• Protect from moisture, and keep the desiccant. Tablets that are moisture-sensitive ship with a desiccant (a silica-gel canister) and say so: "Protect from moisture and light. Store tablets in the original blister package until use" (Fosamax Plus D). Do not pour those tablets into a weekly pill box — the desiccant and the original package are the protection. This is also why nitroglycerin stays in its original glass bottle and why some products say "Store and dispense in the original container."
• Original container, original date. The manufacturer's expiration date belongs to the product in its original packaging. Once a product is repackaged or mixed, a new date — the beyond-use date (BUD) — applies, and the pharmacy's label must carry it. (The BUD rules live in NDC, lot, expiration and returns.)

Restricted access

Some drugs are stored where not everyone can reach them:

• Controlled substances (schedules II–V) are kept under restricted access. Federal law (21 CFR 1301.75(b)) gives a pharmacy two allowed methods: a securely locked, substantially constructed cabinet, or dispersal throughout the stock of noncontrolled substances in a manner that obstructs theft or diversion. "Locked" is one lawful choice, not the only one. That is the storage half of KA 1.8's "restricted access" wording; the inventory and recordkeeping behind it are covered in controlled substances (Domain 2).
• Hazardous drugs (below) and high-alert drugs may be stored in a segregated, labeled area.

What a technician does: access is a policy, not a personal call. If a controlled substance is not where the log says it should be, or a storage unit is unlocked, that is a report to the pharmacist, not something to quietly fix.

Hazardous drugs

A hazardous drug is one that can harm the people who handle it — not only the patient. The reference list is NIOSH's List of Hazardous Drugs in Healthcare Settings, whose current edition is the 2024 list (NIOSH Publication No. 2025-103, December 2024; it "supersedes the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016", and added 25 drugs and removed 7). NIOSH groups the list into two tables, defined in the list's own words:

• Table 1 holds "drugs that have MSHI in the package insert and/or meet the NIOSH definition of a hazardous drug and one or more of these criteria: are classified by the National Toxicology Program (NTP) as 'known to be a human carcinogen'; are classified by the International Agency for Research on Cancer (IARC) as Group 1 'carcinogenic to humans' or Group 2A 'probably carcinogenic to humans.'" — methotrexate (#150 in this course's Top-200) is an example.
• Table 2 holds "drugs that meet the NIOSH definition of a hazardous drug and do not have MSHI, are not classified by NTP as 'known to be a human carcinogen,' and are not classified by the IARC as Group 1 … or Group 2A …" — finasteride (#62) and divalproex sodium (#82) are Top-200 drugs on Table 2 flagged for developmental and/or reproductive risk, and estradiol (#83) is on Table 2 without that reproductive-only flag.

The exam leans on the examples — many chemotherapy agents, some antivirals and hormone therapies, and other drugs flagged for reproductive risk.

What makes handling different. A hazardous drug is not crushed in an open tray, not counted with a shared tray, and not prepared without the right engineering controls and PPE. The technical rules — the containment strategy, the PPE, the closed-system transfer devices, the cleaning — are USP <800>, which is Domain 3 (infection control and compounding). For this topic the point is smaller and firmer: you recognize a hazardous drug from the list, you do not improvise its handling, and a hazardous drug is never crushed the way an ordinary tablet is.

Two sentences to carry out of this topic

Read section 16 — the form tells you the route, and the label tells you the clock. And: the in-use number, the discard day and the temperature range are per product, not per class; when the form, the route or the storage could hurt a patient, the answer is "refer to the pharmacist."

Where to go next

• Next topic — controlled substances
• The exam itself — the passing score, how many questions, and what makes the PTCB exam hard.

This topic sits inside Domain 1 — Medications, 35% of the exam — the outline's own weight, and PTCB publishes no per-knowledge-area split.

PTCE® is a registered trademark of the Pharmacy Technician Certification Board (PTCB). Elk Ridge Academy is not affiliated with or endorsed by PTCB.